SIBN Stock Summary and Trading Ideas (Si-Bone | NASDAQ:SIBN)

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Si-Bone trades on the NASDAQ stock market under the symbol SIBN.

As of January 2, 2026, SIBN stock price climbed to $19.79 with 471,934 million shares trading.

SIBN has a beta of 0.55, meaning it tends to be less sensitive to market movements. SIBN has a correlation of 0.03 to the broad based SPY ETF.

SIBN has a market cap of $858.71 million. This is considered a Small Cap stock.

Last quarter Si-Bone reported $49 million in Revenue and -$.11 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.05.

In the last 3 years, SIBN traded as high as $29.51 and as low as $11.70.

The top ETF exchange traded funds that SIBN belongs to (by Net Assets): VTI, IWM, VXF, IWO, IHI.

SIBN has outperformed the market in the last year with a return of +42.1%, while the SPY ETF gained +18.1%. In the last 3 month period, SIBN beat the market returning +38.3%, while SPY returned +2.4%. However, in the most recent 2 weeks SIBN has underperformed the stock market by returning -2.9%, while SPY returned +0.4%.

SIBN support price is $19.22 and resistance is $20.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SIBN shares will trade within this expected range on the day.